Paul Grewal, Chief Legal Officer, on May 27, 2026, sold 1,960 shares in Coinbase Global (COIN) for $346,683. Following the Form 4 filing with the SEC, Grewal has control over a total of 84,753 Class A common shares of the company, with 84,753 shares held directly.
SEC Filing:
Bruce E Kiddoo, Director, on May 28, 2026, sold 750 shares in Western Digital (WDC) for $396,390. Following the Form 4 filing with the SEC, Kiddoo has control over a total of 3,903 common shares of the company, with 3,903 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/106040/000126682426000113/xslF345X05/edgardoc.xml
Samuel Joseph Parisi, Vice President, Finance (Interim Principal Accounting Officer), on May 29, 2026, sold 16,217 shares in Alkermes (ALKS) for $687,007. Following the Form 4 filing with the SEC, Parisi Samuel Joseph has control over a total of 7,717 ordinary shares of the company, with 7,717 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/xslF345X05/form4.xml
Sean Maduck, President of Corcept Endocrinology, on May 27, 2026, sold 75,000 shares in Corcept Therapeutics (CORT) for $4,918,944. Following the Form 4 filing with the SEC, Maduck has control over a total of 118,694 common shares of the company, with 8,977 shares held directly and 109,717 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1088856/000119312526248967/xslF345X05/ownership.xml